1
|
Terrile MC, Tebez NM, Colman SL, Mateos JL, Morato-López E, Sánchez-López N, Izquierdo-Álvarez A, Marina A, Calderón Villalobos LIA, Estelle M, Martínez-Ruiz A, Fiol DF, Casalongué CA, Iglesias MJ. S-Nitrosation of E3 Ubiquitin Ligase Complex Components Regulates Hormonal Signalings in Arabidopsis. FRONTIERS IN PLANT SCIENCE 2022; 12:794582. [PMID: 35185952 PMCID: PMC8854210 DOI: 10.3389/fpls.2021.794582] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/13/2021] [Accepted: 12/13/2021] [Indexed: 06/01/2023]
Abstract
E3 ubiquitin ligases mediate the last step of the ubiquitination pathway in the ubiquitin-proteasome system (UPS). By targeting transcriptional regulators for their turnover, E3s play a crucial role in every aspect of plant biology. In plants, SKP1/CULLIN1/F-BOX PROTEIN (SCF)-type E3 ubiquitin ligases are essential for the perception and signaling of several key hormones including auxins and jasmonates (JAs). F-box proteins, TRANSPORT INHIBITOR RESPONSE 1 (TIR1) and CORONATINE INSENSITIVE 1 (COI1), bind directly transcriptional repressors AUXIN/INDOLE-3-ACETIC ACID (AUX/IAA) and JASMONATE ZIM-DOMAIN (JAZ) in auxin- and JAs-depending manner, respectively, which permits the perception of the hormones and transcriptional activation of signaling pathways. Redox modification of proteins mainly by S-nitrosation of cysteines (Cys) residues via nitric oxide (NO) has emerged as a valued regulatory mechanism in physiological processes requiring its rapid and versatile integration. Previously, we demonstrated that TIR1 and Arabidopsis thaliana SKP1 (ASK1) are targets of S-nitrosation, and these NO-dependent posttranslational modifications enhance protein-protein interactions and positively regulate SCFTIR1 complex assembly and expression of auxin response genes. In this work, we confirmed S-nitrosation of Cys140 in TIR1, which was associated in planta to auxin-dependent developmental and stress-associated responses. In addition, we provide evidence on the modulation of the SCFCOI1 complex by different S-nitrosation events. We demonstrated that S-nitrosation of ASK1 Cys118 enhanced ASK1-COI1 protein-protein interaction. Overexpression of non-nitrosable ask1 mutant protein impaired the activation of JA-responsive genes mediated by SCFCOI1 illustrating the functional relevance of this redox-mediated regulation in planta. In silico analysis positions COI1 as a promising S-nitrosation target, and demonstrated that plants treated with methyl JA (MeJA) or S-nitrosocysteine (NO-Cys, S-nitrosation agent) develop shared responses at a genome-wide level. The regulation of SCF components involved in hormonal perception by S-nitrosation may represent a key strategy to determine the precise time and site-dependent activation of each hormonal signaling pathway and highlights NO as a pivotal molecular player in these scenarios.
Collapse
Affiliation(s)
- Maria Cecilia Terrile
- Instituto de Investigaciones Biológicas, UE-CONICET-UNMDP, Facultad de Exactas y Naturales, Universidad Nacional de Mar del Plata, Mar del Plata, Argentina
| | - Nuria Malena Tebez
- Instituto de Investigaciones Biológicas, UE-CONICET-UNMDP, Facultad de Exactas y Naturales, Universidad Nacional de Mar del Plata, Mar del Plata, Argentina
| | - Silvana Lorena Colman
- Instituto de Investigaciones Biológicas, UE-CONICET-UNMDP, Facultad de Exactas y Naturales, Universidad Nacional de Mar del Plata, Mar del Plata, Argentina
| | - Julieta Lisa Mateos
- Instituto de Fisiología, Biología Molecular y Neurociencias (IFIBYNE), CONICET-UBA, Buenos Aires, Argentina
| | - Esperanza Morato-López
- Servicio de Proteómica, Centro de Biología Molecular “Severo Ochoa”, CSIC-UAM, Madrid, Spain
| | - Nuria Sánchez-López
- Servicio de Proteómica, Centro de Biología Molecular “Severo Ochoa”, CSIC-UAM, Madrid, Spain
| | - Alicia Izquierdo-Álvarez
- Unidad de Investigación, Hospital Universitario Santa Cristina, Instituto de Investigación Sanitaria Princesa (IIS-IP), Madrid, Spain
| | - Anabel Marina
- Servicio de Proteómica, Centro de Biología Molecular “Severo Ochoa”, CSIC-UAM, Madrid, Spain
| | - Luz Irina A. Calderón Villalobos
- Molecular Signal Processing Department, Leibniz Institute of Plant Biochemistry (IPB), Halle (Saale), Germany
- KWS Gateway Research Center, LLC., BRDG Park at The Danforth Plant Science Center, St. Louis, MO, United States
| | - Mark Estelle
- Section of Cell and Developmental Biology, University of California, San Diego, La Jolla, CA, United States
| | - Antonio Martínez-Ruiz
- Unidad de Investigación, Hospital Universitario Santa Cristina, Instituto de Investigación Sanitaria Princesa (IIS-IP), Madrid, Spain
| | - Diego Fernando Fiol
- Instituto de Investigaciones Biológicas, UE-CONICET-UNMDP, Facultad de Exactas y Naturales, Universidad Nacional de Mar del Plata, Mar del Plata, Argentina
| | - Claudia Anahí Casalongué
- Instituto de Investigaciones Biológicas, UE-CONICET-UNMDP, Facultad de Exactas y Naturales, Universidad Nacional de Mar del Plata, Mar del Plata, Argentina
| | - María José Iglesias
- Instituto de Investigaciones Biológicas, UE-CONICET-UNMDP, Facultad de Exactas y Naturales, Universidad Nacional de Mar del Plata, Mar del Plata, Argentina
- Instituto de Fisiología, Biología Molecular y Neurociencias (IFIBYNE), CONICET-UBA, Buenos Aires, Argentina
| |
Collapse
|
2
|
Downregulation of thioredoxin-1-dependent CD95 S-nitrosation by Sorafenib reduces liver cancer. Redox Biol 2020; 34:101528. [PMID: 32388267 PMCID: PMC7210585 DOI: 10.1016/j.redox.2020.101528] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/25/2020] [Accepted: 03/27/2020] [Indexed: 12/30/2022] Open
Abstract
Hepatocellular carcinoma (HCC) represents 80% of the primary hepatic neoplasms. It is the sixth most frequent neoplasm, the fourth cause of cancer-related death, and 7% of registered malignancies. Sorafenib is the first line molecular targeted therapy for patients in advanced stage of HCC. The present study shows that Sorafenib exerts free radical scavenging properties associated with the downregulation of nuclear factor E2-related factor 2 (Nrf2)-regulated thioredoxin 1 (Trx1) expression in liver cancer cells. The experimental downregulation and/or overexpression strategies showed that Trx1 induced activation of nitric oxide synthase (NOS) type 3 (NOS3) and S-nitrosation (SNO) of CD95 receptor leading to an increase of caspase-8 activity and cell proliferation, as well as reduction of caspase-3 activity in liver cancer cells. In addition, Sorafenib transiently increased mRNA expression and activity of S-nitrosoglutathione reductase (GSNOR) in HepG2 cells. Different experimental models of hepatocarcinogenesis based on the subcutaneous implantation of HepG2 cells in nude mice, as well as the induction of HCC by diethylnitrosamine (DEN) confirmed the relevance of Trx1 downregulation during the proapoptotic and antiproliferative properties induced by Sorafenib. In conclusion, the induction of apoptosis and antiproliferative properties by Sorafenib were related to Trx1 downregulation that appeared to play a relevant role on SNO of NOS3 and CD95 in HepG2 cells. The transient increase of GSNOR might also participate in the deactivation of CD95-dependent proliferative signaling in liver cancer cells. Sorafenib induces mitochondrial ROS generation, but also acts as nucleophilic scavenger. Sorafenib reduces Nrf2-depenent Trx1 expression, and SNO–NOS3 and SNO-CD95 ratios. Sorafenib-related antitumoral in vivo activity involves diminution of Trx1 and SNO-CD95.
Collapse
|
3
|
Santos AI, Lourenço AS, Simão S, Marques da Silva D, Santos DF, Onofre de Carvalho AP, Pereira AC, Izquierdo-Álvarez A, Ramos E, Morato E, Marina A, Martínez-Ruiz A, Araújo IM. Identification of new targets of S-nitrosylation in neural stem cells by thiol redox proteomics. Redox Biol 2020; 32:101457. [PMID: 32088623 PMCID: PMC7038503 DOI: 10.1016/j.redox.2020.101457] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/03/2019] [Revised: 02/05/2020] [Accepted: 02/06/2020] [Indexed: 01/09/2023] Open
Abstract
Nitric oxide (NO) is well established as a regulator of neurogenesis. NO increases the proliferation of neural stem cells (NSC), and is essential for hippocampal injury-induced neurogenesis following an excitotoxic lesion. One of the mechanisms underlying non-classical NO cell signaling is protein S-nitrosylation. This post-translational modification consists in the formation of a nitrosothiol group (R-SNO) in cysteine residues, which can promote formation of other oxidative modifications in those cysteine residues. S-nitrosylation can regulate many physiological processes, including neuronal plasticity and neurogenesis. In this work, we aimed to identify S-nitrosylation targets of NO that could participate in neurogenesis. In NSC, we identified a group of proteins oxidatively modified using complementary techniques of thiol redox proteomics. S-nitrosylation of some of these proteins was confirmed and validated in a seizure mouse model of hippocampal injury and in cultured hippocampal stem cells. The identified S-nitrosylated proteins are involved in the ERK/MAPK pathway and may be important targets of NO to enhance the proliferation of NSC.
Collapse
Affiliation(s)
- Ana Isabel Santos
- Centre for Biomedical Research, CBMR, University of Algarve, 8005-139, Faro, Portugal; Department of Biomedical Sciences and Medicine, University of Algarve, 8005-139, Faro, Portugal; Algarve Biomedical Center, University of Algarve, 8005-139, Faro, Portugal; Centre for Neuroscience and Cell Biology, University of Coimbra, 3004-527, Coimbra, Portugal
| | - Ana Sofia Lourenço
- Centre for Biomedical Research, CBMR, University of Algarve, 8005-139, Faro, Portugal; Department of Biomedical Sciences and Medicine, University of Algarve, 8005-139, Faro, Portugal; Algarve Biomedical Center, University of Algarve, 8005-139, Faro, Portugal; Centre for Neuroscience and Cell Biology, University of Coimbra, 3004-527, Coimbra, Portugal
| | - Sónia Simão
- Centre for Biomedical Research, CBMR, University of Algarve, 8005-139, Faro, Portugal; Department of Biomedical Sciences and Medicine, University of Algarve, 8005-139, Faro, Portugal; Algarve Biomedical Center, University of Algarve, 8005-139, Faro, Portugal
| | - Dorinda Marques da Silva
- Centre for Biomedical Research, CBMR, University of Algarve, 8005-139, Faro, Portugal; Algarve Biomedical Center, University of Algarve, 8005-139, Faro, Portugal
| | - Daniela Filipa Santos
- Centre for Biomedical Research, CBMR, University of Algarve, 8005-139, Faro, Portugal; Algarve Biomedical Center, University of Algarve, 8005-139, Faro, Portugal
| | | | - Ana Catarina Pereira
- Department of Biomedical Sciences and Medicine, University of Algarve, 8005-139, Faro, Portugal
| | - Alicia Izquierdo-Álvarez
- Servicio de Inmunología, Hospital Universitario de la Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP), 28006, Madrid, Spain
| | - Elena Ramos
- Servicio de Inmunología, Hospital Universitario de la Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP), 28006, Madrid, Spain
| | - Esperanza Morato
- Servicio de Proteómica, Centro de Biología Molecular Severo Ochoa (CBMSO), Universidad Autónoma de Madrid (UAM) & Consejo Superior de Investigaciones Científicas (CSIC), 28049, Madrid, Spain
| | - Anabel Marina
- Servicio de Proteómica, Centro de Biología Molecular Severo Ochoa (CBMSO), Universidad Autónoma de Madrid (UAM) & Consejo Superior de Investigaciones Científicas (CSIC), 28049, Madrid, Spain
| | - Antonio Martínez-Ruiz
- Servicio de Inmunología, Hospital Universitario de la Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP), 28006, Madrid, Spain; Unidad de Investigación, Hospital Universitario Santa Cristina, Instituto de Investigación Sanitaria Princesa (IIS-IP), 28009, Madrid, Spain; Departamento de Bioquímica y Biología Molecular, Facultad de Farmacia, Universidad Complutense de Madrid, 28040, Madrid, Spain; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Spain.
| | - Inês Maria Araújo
- Centre for Biomedical Research, CBMR, University of Algarve, 8005-139, Faro, Portugal; Department of Biomedical Sciences and Medicine, University of Algarve, 8005-139, Faro, Portugal; Algarve Biomedical Center, University of Algarve, 8005-139, Faro, Portugal.
| |
Collapse
|
4
|
López-Rodríguez JC, Manosalva J, Cabrera-García JD, Escribese MM, Villalba M, Barber D, Martínez-Ruiz A, Batanero E. Human glutathione-S-transferase pi potentiates the cysteine-protease activity of the Der p 1 allergen from house dust mite through a cysteine redox mechanism. Redox Biol 2019; 26:101256. [PMID: 31229842 PMCID: PMC6597738 DOI: 10.1016/j.redox.2019.101256] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/24/2019] [Revised: 05/30/2019] [Accepted: 06/10/2019] [Indexed: 11/30/2022] Open
Abstract
Environmental proteases have been widely associated to the pathogenesis of allergic disorders. Der p 1, a cysteine-protease from house dust mite (HDM) Dermatophagoides pteronyssinus, constitutes one of the most clinically relevant indoor aeroallergens worldwide. Der p 1 protease activity depends on the redox status of its catalytic cysteine residue, which has to be in the reduced state to be active. So far, it is unknown whether Der p 1-protease activity could be regulated by host redox microenvironment once it reaches the lung epithelial lining fluid in addition to endogenous mite components. In this sense, Glutathione-S-transferase pi (GSTpi), an enzyme traditionally linked to phase II detoxification, is highly expressed in human lung epithelial cells, which represent the first line of defence against aeroallergens. Moreover, GSTpi is a generalist catalyst of protein S-glutathionylation reactions, and some polymorphic variants of this enzyme has been associated to the development of allergic asthma. Here, we showed that human GSTpi increased the cysteine-protease activity of Der p 1, while GSTmu (the isoenzyme produced by the mite) did not alter it. GSTpi induces the reduction of Cys residues in Der p 1, probably by rearranging its disulphide bridges. Furthermore, GSTpi was detected in the apical medium collected from human bronchial epithelial cell cultures, and more interesting, it increased cysteine-protease activity of Der p 1. Our findings support the role of human GSTpi from airways in modulating of Der p 1 cysteine-protease activity, which may have important clinical implications for immune response to this aeroallergen in genetically susceptible individuals.
Collapse
Affiliation(s)
- Juan Carlos López-Rodríguez
- Departamento de Bioquímica y Biología Molecular, Facultad de Ciencias Químicas, Universidad Complutense, Madrid, Spain
| | - Juliana Manosalva
- Departamento de Bioquímica y Biología Molecular, Facultad de Ciencias Químicas, Universidad Complutense, Madrid, Spain
| | - J Daniel Cabrera-García
- Unidad de Investigación, Hospital Santa Cristina, Instituto de Investigación Sanitaria Princesa (IIS-IP), Madrid, Spain
| | - María M Escribese
- Instituto de Medicina Molecular Aplicada (IMMA), Universidad San Pablo CEU, Madrid, Spain
| | - Mayte Villalba
- Departamento de Bioquímica y Biología Molecular, Facultad de Ciencias Químicas, Universidad Complutense, Madrid, Spain
| | - Domingo Barber
- Instituto de Medicina Molecular Aplicada (IMMA), Universidad San Pablo CEU, Madrid, Spain
| | - Antonio Martínez-Ruiz
- Unidad de Investigación, Hospital Santa Cristina, Instituto de Investigación Sanitaria Princesa (IIS-IP), Madrid, Spain; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Spain.
| | - Eva Batanero
- Departamento de Bioquímica y Biología Molecular, Facultad de Ciencias Químicas, Universidad Complutense, Madrid, Spain.
| |
Collapse
|